Foresite Capital Management V, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Foresite Capital Management V, LLC reported 5 stock positions worth $106.5 million. Its top holding was Hims & Hers Health (HIMS) at 48.3% of the portfolio, followed by CG Oncology (CGON, 28.5%) and Disc Medicine (IRON, 14.2%). Compared with Q4 2023, it opened 1 new position, sold out of 1 and reduced 1. The biggest buy was a new position in CG Oncology (CGON) and the biggest sale an exit from Theseus Pharmaceuticals (THRX).
- Most Recent 13F
- Q2 2026
- Location
- WEST HOLLYWOOD, CA
- CIK
- 0001792206
- Portfolio Value
- $106.5M (Q1 2024)
- SEC Filing
- 0001104659-24-061748 ↗ filed May 15, 2024
Holdings Value
Holdings 5 stocks · $106.5M
| HIMS Hims & Hers Health Inc. | 48.31% | 3,326,783 | $51.5M | Reduce -13.2% |
| CGON CG Oncology Inc. | 28.54% | 692,550 | $30.4M | New |
| IRON Disc Medicine Inc. | 14.23% | 243,513 | $15.2M | No change |
| KNTE Kinnate Biopharma Inc. | 8.80% | 3,525,957 | $9.4M | No change |
| 23ANDME HOLDING CO | 0.12% | 232,200 | $124K | No change |
Portfolio Sells Q4 2023 → Q1 2024
Portfolio Buys Q4 2023 → Q1 2024
| CGON CG Oncology Inc. | New | 28.54% | +28.54 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $362.2M | ALMS, CGON, IRON, HIMS, PHVS |
| Q1 2026 | 9 | $271.0M | ALMS, CGON, IRON, HIMS, EIKN |
| Q4 2025 | 7 | $164.4M | ALMS, CGON, IRON, NTRA, LYEL |
| Q3 2025 | 6 | $108.7M | CGON, ALMS, IRON, HIMS, LYEL |
| Q2 2025 | 6 | $80.7M | CGON, ALMS, IRON, HIMS, MAZE |
| Q1 2025 | 6 | $87.6M | ALMS, CGON, IRON, HIMS, LYEL |
| Q4 2024 | 6 | $120.2M | ALMS, HIMS, CGON, IRON, CGEM |
| Q3 2024 | 5 | $143.9M | ALMS, HIMS, CGON, IRON, CGEM |
| Q2 2024 | 5 | $156.6M | ALMS, HIMS, CGON, IRON, CGEM |
| Q1 2024 | 5 | $106.5M | HIMS, CGON, IRON, KNTE, 23ANDME HOLDING CO |